Retrospective Study
Copyright ©The Author(s) 2024.
World J Psychiatry. May 19, 2024; 14(5): 653-660
Published online May 19, 2024. doi: 10.5498/wjp.v14.i5.653
Table 1 Comparison of baseline data
Baseline information
Observer group (n = 70)
Control group (n = 70)
χ2/t value
P value
Sexuality [n (%)]0.0290.866
Males37 (52.86)36 (51.43)
Females33 (47.14)34 (48.57)
Age (mean ± SD/yr)44.62 ± 9.5846.37 ± 9.421.0900.278
Course of disease (mean ± SD/yr)4.39 ± 0.444.31 ± 0.650.8530.395
HAMD (mean ± SD/score)30.88 ± 4.1629.65 ± 3.721.8440.067
Table 2 Comparison of clinical efficacy between the two groups [n (%)]
Groups
Recovery
Effectual
Improvement
Null and void
Total effective rates
Control group
(n = 70)
7 (10.00)14 (20.00)31 (44.29)18 (25.71)52 (74.29)
Observer group
(n = 70)
12 (17.14)20 (28.57)32 (45.72)6 (8.57)64 (91.43)
χ2/t value8.3907.241
P value0.0390.007
Table 3 Comparison of self-rating idea of suicide scale and Pittsburgh Sleep Quality Index scores between the two groups before and after treatment (mean ± SD)
Groups
Times
SSIOS/score
PSQI/score
Control group (n = 70)Before treatment18.55 ± 4.0215.83 ± 1.76
After treatment0.87 ± 0.127.94 ± 1.35
t36.78029.760
P value< 0.001< 0.001
Observer group (n = 70)Before treatment18.88 ± 4.0615.36 ± 2.54
After treatment1.67 ± 0.28a5.29 ± 1.33a
t value35.38029.390
P value< 0.001< 0.001
Table 4 Comparison of quality of life between the two groups (mean ± SD)
Groups
Social function
Emotions
Environment
Physical health
Control group (n = 70)16.23 ± 2.3412.28 ± 2.1616.56 ± 3.4416.62 ± 3.46
Observer group (n = 70)19.25 ± 2.7618.54 ± 2.8318.49 ± 2.4819.53 ± 2.39
t value6.98314.7103.8085.790
P value< 0.001< 0.001< 0.001< 0.001